国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2011年
17期
2107-2110
,共4页
林岚%陈力%张春玲%杨延萍%肖玉联
林嵐%陳力%張春玲%楊延萍%肖玉聯
림람%진력%장춘령%양연평%초옥련
佝偻病%骨碱性磷酸酶%碱性磷酸酶
佝僂病%骨堿性燐痠酶%堿性燐痠酶
구루병%골감성린산매%감성린산매
Rickets%Bone alkaline phosphatase%Alkaline phosphatase
目的 了解定量骨碱性磷酸酶( BAP-E)、定性骨碱性磷酸酶(BAP-CIT)、血清碱性磷酸酶(AP)三个指标在佝偻病诊断中的意义。方法 检测55例佝偻病患儿、26例对照婴幼儿血清AP、BAP-E、BAP-CIT,BAP-E采用ELISA法,BAP-CIT用全血干化学和免疫浓缩技术。结果 佝偻病患儿的AP和BAP-E较对照组(164.38 U/L±23.87 U/L,57.99 U/L±7.67 U/L)明显增高(P<0.05),中、重度组佝偻病患儿的AP和BAP-E( 1000.47 U/L±464.65U/L,283.22 U/L±96.42 U/L)较轻度组(209.50 U/L±44.28 U/L,80.38 U/L±15.75 U/L;206.06 U/L±30.80 U/L,78.05 U/L±11.69 U/L)明显增高(P<0.05),对照组BAP-CIT仅1例在试剂盒的正常范围≤200 U/L,余皆在异常范围(200-300) U/L,AP与BAP-E、BAP-CIT均呈显著正相关(r=0.921,0.49,P<0.01)。结论 AP、BAP-E与佝偻病的严重程度呈正相关,严重的佝偻病患儿可选用AP,BAP-CIT在佝偻病诊断的应用中要慎重。
目的 瞭解定量骨堿性燐痠酶( BAP-E)、定性骨堿性燐痠酶(BAP-CIT)、血清堿性燐痠酶(AP)三箇指標在佝僂病診斷中的意義。方法 檢測55例佝僂病患兒、26例對照嬰幼兒血清AP、BAP-E、BAP-CIT,BAP-E採用ELISA法,BAP-CIT用全血榦化學和免疫濃縮技術。結果 佝僂病患兒的AP和BAP-E較對照組(164.38 U/L±23.87 U/L,57.99 U/L±7.67 U/L)明顯增高(P<0.05),中、重度組佝僂病患兒的AP和BAP-E( 1000.47 U/L±464.65U/L,283.22 U/L±96.42 U/L)較輕度組(209.50 U/L±44.28 U/L,80.38 U/L±15.75 U/L;206.06 U/L±30.80 U/L,78.05 U/L±11.69 U/L)明顯增高(P<0.05),對照組BAP-CIT僅1例在試劑盒的正常範圍≤200 U/L,餘皆在異常範圍(200-300) U/L,AP與BAP-E、BAP-CIT均呈顯著正相關(r=0.921,0.49,P<0.01)。結論 AP、BAP-E與佝僂病的嚴重程度呈正相關,嚴重的佝僂病患兒可選用AP,BAP-CIT在佝僂病診斷的應用中要慎重。
목적 료해정량골감성린산매( BAP-E)、정성골감성린산매(BAP-CIT)、혈청감성린산매(AP)삼개지표재구루병진단중적의의。방법 검측55례구루병환인、26례대조영유인혈청AP、BAP-E、BAP-CIT,BAP-E채용ELISA법,BAP-CIT용전혈간화학화면역농축기술。결과 구루병환인적AP화BAP-E교대조조(164.38 U/L±23.87 U/L,57.99 U/L±7.67 U/L)명현증고(P<0.05),중、중도조구루병환인적AP화BAP-E( 1000.47 U/L±464.65U/L,283.22 U/L±96.42 U/L)교경도조(209.50 U/L±44.28 U/L,80.38 U/L±15.75 U/L;206.06 U/L±30.80 U/L,78.05 U/L±11.69 U/L)명현증고(P<0.05),대조조BAP-CIT부1례재시제합적정상범위≤200 U/L,여개재이상범위(200-300) U/L,AP여BAP-E、BAP-CIT균정현저정상관(r=0.921,0.49,P<0.01)。결론 AP、BAP-E여구루병적엄중정도정정상관,엄중적구루병환인가선용AP,BAP-CIT재구루병진단적응용중요신중。
Objective To explore the significance of quantitative and qualitative measurements of bone alkaline phosphatase ( BAP-E and BAP-CIT ) and detection of serum AP in the diagnosis of rickets. Methods Serum AP level was measured, quantitative BAP was detected by ELISA, and qualitative BAP was determined by CIT in 55 children with rickets and 26 control subjects. Results AP level and BAP-E were ( 164.38 ± 23.87 ) U/L and ( 57.99 ± 7.67 ) U/L in controls, and were ( 209.50 ± 44.28 ) U/L, ( 80.38 ± 15.75 ) U/L, ( 206.06 ± 30.80 ) U/L, ( 78.05± 11.69) U/L, ( 1000.47 ± 464.65) U/L, and (283.22 ± 96.42) U/L in mild or severe rickets ,respectively. AP and BAP-E were elevated significantly in children with rickets ( P< 0.05 ), and there were significant differences between the severe groups and the mild groups ( P < 0.05 ). AP positively related with BAP-E ( r= 0.921, P< 0.01 ) and BAP-CIT ( r= 0.49, P< 0.01 ). In the control group,BAP-CIT within the normal range was only in one patient and that beyond the normal range was in the remaining patients. Conclusions AP and BAP-E are positively correlated with the severity of rickets.AP may be used in severe patients. BAP-CIT should be used carefully in the diagnosis of rickets.